Zhejiang Jianfeng Group's subsidiary, which produces injectable special citicoline, has obtained a drug registration certificate.
Jianfeng Group (600668.SH) announced that its wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. has recently received the Injection Phosphatidylcholine Certificate of Pharmaceutical Registration issued by the National Medical Products Administration. Phosphatidylcholine is used in the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by sensitive strains of the following gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus [MRSA] and methicillin-sensitive Staphylococcus aureus [MSSA] strains), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus anginosus group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus), and Enterococcus.
Zhejiang Jianfeng Group (600668.SH) announced that its wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Limited Company has received the "Drug Registration Certificate" for the injection of Tedizolid phosphate issued by the National Medical Products Administration. Tedizolid phosphate is used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by sensitive strains of the following Gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus [MRSA] and methicillin-sensitive Staphylococcus aureus [MSSA] strains), Streptococcus pyogenes, Streptococcus agalactiae, the Streptococcus anginosus group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus), and Enterococcus faecalis.
Related Articles
Haier Smart Home (06690) spent 42.288 million yuan on July 24 to repurchase 1.94 million A shares.
SINOPEC CORP (00386) spent 5.184 million yuan on July 24 to repurchase 1 million A shares.
GUSHENGTANG (02273) spent approximately HK$2.2085 million on July 24th to repurchase 77,800 shares.
Haier Smart Home (06690) spent 42.288 million yuan on July 24 to repurchase 1.94 million A shares.
SINOPEC CORP (00386) spent 5.184 million yuan on July 24 to repurchase 1 million A shares.
GUSHENGTANG (02273) spent approximately HK$2.2085 million on July 24th to repurchase 77,800 shares.
RECOMMEND
